August 27, 2007
DNA Provides Clues To Outcome In Patients With Liver CancerTopics: Liver Cancer
Researchers at the National Institutes of Health, Bethesda, are shedding some light on molecular pathways activated by the triggers of liver cancer, by showing that the genome of a person's liver cancer cells is modified by a process known as methylation, and that it correlates with their clinical outcome. The researchers suggest that preventing aberrant methylation or targeting the genes whose expression is altered by the aberrant methylation might provide new targets for the treatment of liver cancer.
Cross posted by Hyscience
Posted by Richard at August 27, 2007 11:53 PM
Articles Related to Liver Cancer: